SJÖGREN'S DISEASE
Clinical trials for SJÖGREN'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new SJÖGREN'S DISEASE trials appear
Sign up with your email to follow new studies for SJÖGREN'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug HBM7020 tested in humans for first time against autoimmune diseases
Disease control Not yet recruitingThis first-in-human study tests the safety of a new drug called HBM7020. It will first be given to healthy volunteers at low doses, then to people with moderate to severe autoimmune diseases like lupus, rheumatoid arthritis, scleroderma, and Sjögren's disease. The goal is to see …
Matched conditions: SJÖGREN'S DISEASE
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New monthly shot could ease Sjögren's dry mouth
Symptom relief Not yet recruitingThis phase 3 study tests whether ianalumab, given as a monthly injection, can reduce dry mouth and other symptoms in people with Sjögren's disease who have a high symptom burden. About 570 adults will receive either the drug or a placebo for 52 weeks. The main goal is to see if t…
Matched conditions: SJÖGREN'S DISEASE
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC